AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2014
Feb 24, 2014
30016_dirs_2014-02-24_e9b95da2-0575-4c32-9fe1-9bfa08b3c92d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2014-02-20
Reporting Person: SZOSTAK M ANNE (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-02-20 | Common Stock | P | 2000 | $126.7128 | Acquired | 5000 | Direct |
Footnotes
F1: The purchase price reported reflects the weighted average purchase price of multiple transactions on the reported date at prices that ranged from $126.65 to $126.83, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range.
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 26